These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6336551)

  • 1. Association of post-anaesthetic hyperthermia with abnormal muscle characteristics: a case report.
    Kripke BJ; Blanck TJ; Sizemore DA; Comunale FL; Christiansen J; Gruener R
    Can Anaesth Soc J; 1983 May; 30(3 Pt 1):290-4. PubMed ID: 6336551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry.
    Larach MG; Landis JR; Bunn JS; Diaz M
    Anesthesiology; 1992 Jan; 76(1):16-27. PubMed ID: 1729931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia suggestive hypermetabolic syndrome at emergence from anesthesia.
    Christiaens F; Gepts E; D'Haese J; Camu F
    Acta Anaesthesiol Belg; 1995; 46(2):93-7. PubMed ID: 8714856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant hyperthermia; two cases of MH in the presence of general anesthesia and performing caffeine contracture test].
    Tateishi M; Sumita S; Watanabe H; Kumeta H; Narimatsu E; Namiki A
    Masui; 1989 Apr; 38(4):546-51. PubMed ID: 2724520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia.
    Ben Abraham R; Adnet P; Glauber V; Perel A
    Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative hyperthermia in a child with neuroblastoma.
    Mayhew JF
    Paediatr Anaesth; 2006 Aug; 16(8):890-1. PubMed ID: 16884475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
    O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
    Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia.
    Rosenberg H; Davis M; James D; Pollock N; Stowell K
    Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N; Brum JM; Mitsumoto H; DeBoer GE
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?
    Nelson TE; Flewellen EH
    Can Anaesth Soc J; 1979 Nov; 26(6):484-8. PubMed ID: 526874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group.
    Ording H; Brancadoro V; Cozzolino S; Ellis FR; Glauber V; Gonano EF; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Kozak-Ribbens G; Kress H; Krivosic-Horber R; Lehmann-Horn F; Mortier W; Nivoche Y; Ranklev-Twetman E; Sigurdsson S; Snoeck M; Stieglitz P; Tegazzin V; Urwyler A; Wappler F
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):955-66. PubMed ID: 9311391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome].
    Silva HC; Bahia VS; Oliveira RA; Marchiori PE; Scaff M; Tsanaclis AM
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):713-9. PubMed ID: 10973114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Central hyperthermia suspected of malignant hyperthermia in a patient undergoing radical neck clipping for cerebral aneurysm].
    Murakawa T; Sakai I; Matsuki A
    Masui; 2005 Jan; 54(1):49-53. PubMed ID: 15717469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia in humans--standardization of contracture testing protocol.
    Melton AT; Martucci RW; Kien ND; Gronert GA
    Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of susceptibility to malignant hyperthermia in children].
    Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
    Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I; Goldberg G; Glauber V; Perel A
    Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
    Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
    Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.
    Nelson TE; Denborough MA
    Clin Exp Pharmacol Physiol; 1977; 4(3):315-22. PubMed ID: 891045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.